OLMA OLEMA PHARMACEUTICALS INC Investments/Divestments 8-K Filing 2024 - Equity Offering Program Olema Pharmaceuticals, Inc. entered into a sales agreement with Cowen and Company, LLC for an at-the-market equity offering program, allowing the company to offer and sell shares of its common stock with an aggregate offering price of up to $150 million.Get access to all SEC 8-K filings of the OLEMA PHARMACEUTICALS INC